Barclays Reaffirms “Overweight” Rating for Assura (LON:AGR)

Assura (LON:AGRGet Rating)‘s stock had its “overweight” rating restated by stock analysts at Barclays in a report released on Monday, Marketbeat reports. They presently have a GBX 80 ($1.01) target price on the real estate investment trust’s stock. Barclays‘s target price points to a potential upside of 15.86% from the company’s current price.

Several other brokerages also recently commented on AGR. Berenberg Bank reissued a “hold” rating and issued a GBX 80 ($1.01) target price on shares of Assura in a report on Wednesday, April 13th. Shore Capital reaffirmed a “buy” rating on shares of Assura in a report on Friday, April 1st. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from, the stock has a consensus rating of “Buy” and an average target price of GBX 79.83 ($1.00).

AGR stock opened at GBX 69.05 ($0.87) on Monday. Assura has a 1-year low of GBX 59.28 ($0.75) and a 1-year high of GBX 80.60 ($1.01). The firm has a market cap of £2.04 billion and a P/E ratio of 13.83. The business’s 50 day moving average is GBX 66.94 and its 200-day moving average is GBX 66.96. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 79.83.

About Assura (Get Rating)

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities.

Further Reading

Analyst Recommendations for Assura (LON:AGR)

Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with's FREE daily email newsletter.